雅培 ABT 深 滬
已收盤 08-07 16:00:00 美东时间
107.81
-0.150
-0.14%
華盛通- 最 高107.97
- 今 開107.03
- 成交量 660.66万股
- 最 低 106.01
- 昨 收 107.96
- 總市值 1865.53亿
- 52周最高 135.01
- 市盈率 靜 28.99
- 換手率 0.38%
- 52周最低 81.34
- 委 比 13.64%
- 總股本 17.30亿
- 歷史最高 137.57
- 量 比 0.75
- 振 幅 1.82%
- 歷史最低 12.35
- 每 手 1
- 風險率 15.79%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Medical devices ETF nears breakout; here are its top holdings
The U.S. Medical Devices ETF (IHI) could be nearing a technical breakout as strength in the broader healthcare sector prompts investors to rotate into lagging industry groups, according to Donovan Jac...
08-07 23:07
3 ‘Strong Buy’ Dividend Aristocrat Stocks to Power Your Cash Flow, 7/30/26
Investors searching for regular cash payments can look to Abbott Laboratories (...
07-31 03:04
美股前瞻 | 今夜联储局决议陷“史诗级”不确定性！升息概率或达三成？SK海力士反驳AI投资放缓担忧；微软、Meta盘后放榜
今夜联储局决议陷“史诗级”不确定性！升息概率或达三成？SK海力士反驳AI投资放缓担忧，称长协不会导致供应过剩；微软、Meta盘后放榜，资本开支回报将成焦点>>
07-29 20:16
抽血查肠癌正式获批，雅培手握双王牌
今年3月，雅培以210亿美元完成对Exact Sciences的收购，将Cologuard粪便DNA检测结直肠癌收入囊中。 四个月后，FDA批准Freeno...
07-29 20:00
美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元
07-29 11:37
财报速睇 | 雅培 2026财年Q2营收125.93亿美元，同比增长13.0%；归母净利润9.00亿美元，同比下滑50.0%
华盛资讯7月29日讯，雅培公布2026财年Q2业绩，公司Q2营收125.93亿美元，同比增长13.0%，归母净利润9.00亿美元，同比下滑50.0%。
07-29 06:34
UBS Maintains Buy on Abbott Laboratories, Lowers Price Target to $125
UBS analyst Patrick Wood maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $135 to $125.
07-29 03:15
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
Freenome and Abbott announce FDA approval of SimpleScreen CRC, a blood-based colorectal cancer screening test for adults aged 45 and older. The test detects cancer signals using cell-free DNA and has shown high accuracy in clinical trials. With Medicare coverage and ACS guidance, it aims to expand screening access for millions overdue. Abbott will commercialize the test in the U.S., adding to its screening portfolio and helping reach unscreened p...
07-27 12:00
当硬件、算法、泵都已就位，是什么在阻止中国糖尿病患者用上人工胰腺？
原标题：当硬件、算法、泵都已就位，是什么在阻止中国糖尿病患者用上人工胰腺？ 来源：动脉网 一个闭环胰岛素输注系统能做什么？ 简单说，就是替患者完成每天重复多次...
07-26 10:40
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Abivax strengthens its commercial capabilities with four strategic leadership appointments to prepare for the potential U.S. commercialization of obefazimod. The new executives, James Berger, Ivan Nuñez-Pacheco, Heather Dean, and Jeff Haas, bring extensive experience in marketing, patient services, sales, and market access. Their expertise will support the planned NDA submission to the FDA in Q4 2026 and enhance Abivax's readiness for a successfu...
07-23 20:05
公司簡介
公司名稱
|
雅培
|
行業分類
|
医疗设备
|
業務描述
|
雅培致力于帮助人们通过健康拥有美好生活。125年多来，雅培不断创新，探索改善健康的解决方案——从营养品、诊断、医疗器械到药品——雅培为人生每个阶段创造更多可能。雅培全球94000多名员工，助力世界150多个国家和地区的人们获得健康精彩人生。雅培在中国运营近30年，总部位于上海，目前拥有超过4000多名员工。
|
Medical devices ETF nears breakout; here are its top holdings
The U.S. Medical Devices ETF (IHI) could be nearing a technical breakout as strength in the broader healthcare sector prompts investors to rotate into lagging industry groups, according to Donovan Jac...
08-07 23:07
3 ‘Strong Buy’ Dividend Aristocrat Stocks to Power Your Cash Flow, 7/30/26
Investors searching for regular cash payments can look to Abbott Laboratories (...
07-31 03:04
美股前瞻 | 今夜联储局决议陷“史诗级”不确定性！升息概率或达三成？SK海力士反驳AI投资放缓担忧；微软、Meta盘后放榜
今夜联储局决议陷“史诗级”不确定性！升息概率或达三成？SK海力士反驳AI投资放缓担忧，称长协不会导致供应过剩；微软、Meta盘后放榜，资本开支回报将成焦点>>
07-29 20:16
抽血查肠癌正式获批，雅培手握双王牌
今年3月，雅培以210亿美元完成对Exact Sciences的收购，将Cologuard粪便DNA检测结直肠癌收入囊中。 四个月后，FDA批准Freeno...
07-29 20:00
美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元
07-29 11:37
财报速睇 | 雅培 2026财年Q2营收125.93亿美元，同比增长13.0%；归母净利润9.00亿美元，同比下滑50.0%
华盛资讯7月29日讯，雅培公布2026财年Q2业绩，公司Q2营收125.93亿美元，同比增长13.0%，归母净利润9.00亿美元，同比下滑50.0%。
07-29 06:34
UBS Maintains Buy on Abbott Laboratories, Lowers Price Target to $125
UBS analyst Patrick Wood maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $135 to $125.
07-29 03:15
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
Freenome and Abbott announce FDA approval of SimpleScreen CRC, a blood-based colorectal cancer screening test for adults aged 45 and older. The test detects cancer signals using cell-free DNA and has shown high accuracy in clinical trials. With Medicare coverage and ACS guidance, it aims to expand screening access for millions overdue. Abbott will commercialize the test in the U.S., adding to its screening portfolio and helping reach unscreened p...
07-27 12:00
当硬件、算法、泵都已就位，是什么在阻止中国糖尿病患者用上人工胰腺？
原标题：当硬件、算法、泵都已就位，是什么在阻止中国糖尿病患者用上人工胰腺？ 来源：动脉网 一个闭环胰岛素输注系统能做什么？ 简单说，就是替患者完成每天重复多次...
07-26 10:40
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Abivax strengthens its commercial capabilities with four strategic leadership appointments to prepare for the potential U.S. commercialization of obefazimod. The new executives, James Berger, Ivan Nuñez-Pacheco, Heather Dean, and Jeff Haas, bring extensive experience in marketing, patient services, sales, and market access. Their expertise will support the planned NDA submission to the FDA in Q4 2026 and enhance Abivax's readiness for a successfu...
07-23 20:05
派息除權日
|
每股總股息
| 派息日期 |
2026-07-15
|
0.63
|
2026-08-17
|
2026-04-15
|
0.63
|
2026-05-15
|
2026-01-15
|
0.63
|
2026-02-13
|
2025-10-15
|
0.59
|
2025-11-17
|
2025-07-15
|
0.59
|
2025-08-15
|
2025-04-15
|
0.59
|
2025-05-15
|
2025-01-15
|
0.59
|
2025-02-14
|
2024-10-15
|
0.55
|
2024-11-15
|
2024-07-15
|
0.55
|
2024-08-15
|
2024-04-12
|
0.55
|
2024-05-15
|
2024-01-11
|
0.55
|
2024-02-15
|
2023-10-12
|
0.51
|
2023-11-15
|
2023-07-13
|
0.51
|
2023-08-15
|
2023-04-13
|
0.51
|
2023-05-15
|
2023-01-12
|
0.51
|
2023-02-15
|
2022-10-13
|
0.47
|
2022-11-15
|
2022-07-14
|
0.47
|
2022-08-15
|
2022-04-13
|
0.47
|
2022-05-16
|
2022-01-13
|
0.47
|
2022-02-15
|
2021-10-14
|
0.45
|
2021-11-15
|
2021-07-14
|
0.45
|
2021-08-16
|
2021-04-14
|
0.45
|
2021-05-17
|
2021-01-14
|
0.45
|
2021-02-16
|
2020-10-14
|
0.36
|
2020-11-16
|
2020-07-14
|
0.36
|
2020-08-17
|
2020-04-14
|
0.36
|
2020-05-15
|
2020-01-14
|
0.36
|
2020-02-14
|
2019-10-11
|
0.32
|
2019-11-15
|
2019-07-12
|
0.32
|
2019-08-15
|
2019-04-12
|
0.32
|
2019-05-15
|
2019-01-14
|
0.32
|
2019-02-15
|
2018-10-12
|
0.28
|
2018-11-15
|
2018-07-12
|
0.28
|
2018-08-15
|
2018-04-12
|
0.28
|
2018-05-15
|
2018-01-11
|
0.28
|
2018-02-15
|
2017-10-12
|
0.26
|
2017-11-15
|
2017-07-12
|
0.26
|
2017-08-15
|
2017-04-11
|
0.26
|
2017-05-15
|
2017-01-11
|
0.26
|
2017-02-15
|
2016-10-12
|
0.26
|
2016-11-15
|
2016-07-13
|
0.26
|
2016-08-15
|
2016-04-13
|
0.26
|
2016-05-16
|
2016-01-13
|
0.26
|
2016-02-16
|
2015-10-13
|
0.24
|
2015-11-15
|
2015-07-13
|
0.24
|
2015-08-15
|
2015-04-13
|
0.24
|
2015-05-15
|
2015-01-13
|
0.24
|
2015-02-13
|
2014-10-10
|
0.22
|
2014-11-15
|
2014-07-11
|
0.22
|
2014-08-15
|
2014-04-11
|
0.22
|
2014-05-15
|
2014-01-13
|
0.22
|
2014-02-15
|
2013-10-10
|
0.14
|
2013-11-15
|
2013-07-11
|
0.14
|
2013-08-15
|
2013-04-11
|
0.14
|
2013-05-15
|
2013-01-11
|
0.14
|
2013-02-15
|
2012-10-11
|
0.51
|
2012-11-15
|
2012-07-11
|
0.51
|
2012-08-15
|
2012-04-11
|
0.51
|
2012-05-15
|
2012-01-11
|
0.48
|
2012-02-15
|
2011-10-12
|
0.48
|
2011-11-15
|
2011-07-13
|
0.48
|
2011-08-15
|
2011-04-13
|
0.48
|
2011-05-16
|
2011-01-12
|
0.44
|
2011-02-15
|
2010-10-13
|
0.44
|
2010-11-15
|
2010-07-13
|
0.44
|
2010-08-15
|
2010-04-13
|
0.44
|
2010-05-15
|
2010-01-13
|
0.40
|
2010-02-15
|
2009-10-13
|
0.40
|
2009-11-15
|
2009-07-13
|
0.40
|
2009-08-15
|
2009-04-13
|
0.40
|
2009-05-15
|
2009-01-13
|
0.36
|
2009-02-15
|
2008-10-10
|
0.36
|
2008-11-15
|
2008-07-11
|
0.36
|
2008-08-15
|
2008-04-11
|
0.36
|
2008-05-15
|
2008-01-11
|
0.32
|
2008-02-15
|
2007-10-11
|
0.32
|
2007-11-15
|
2007-07-11
|
0.32
|
2007-08-15
|
2007-04-11
|
0.32
|
2007-05-15
|
2007-01-10
|
0.29
|
2007-02-15
|
2006-10-11
|
0.29
|
2006-11-15
|
2006-07-12
|
0.29
|
2006-08-15
|
2006-04-11
|
0.29
|
2006-05-15
|
2006-01-11
|
0.28
|
2006-02-15
|
2005-10-12
|
0.28
|
2005-11-15
|
2005-07-13
|
0.28
|
2005-08-15
|
2005-04-13
|
0.28
|
2005-05-15
|
2005-01-12
|
0.26
|
2005-02-15
|
2004-10-13
|
0.26
|
2004-11-15
|
2004-07-13
|
0.26
|
2004-08-15
|
2004-04-13
|
0.26
|
2004-05-15
|
2004-01-13
|
0.25
|
2004-02-15
|
2003-10-10
|
0.25
|
2003-11-15
|
2003-07-11
|
0.25
|
2003-08-15
|
2003-04-11
|
0.25
|
2003-05-15
|
2003-01-13
|
0.23
|
2003-02-15
|
2002-10-10
|
0.23
|
2002-11-15
|
2002-07-11
|
0.23
|
2002-08-15
|
2002-04-11
|
0.23
|
2002-05-15
|
2002-01-11
|
0.21
|
2002-02-15
|
2001-10-11
|
0.21
|
2001-11-15
|
2001-07-11
|
0.21
|
2001-08-15
|
2001-04-10
|
0.21
|
2001-05-15
|
2001-01-10
|
0.19
|
2001-02-15
|
2000-10-11
|
0.19
|
2000-11-15
|
2000-07-12
|
0.19
|
2000-08-15
|
2000-04-12
|
0.19
|
2000-05-15
|
2000-01-12
|
0.17
|
2000-02-15
|
1999-10-13
|
0.17
|
1999-11-15
|
1999-07-13
|
0.17
|
1999-08-15
|
1999-04-13
|
0.17
|
1999-05-15
|
1999-01-13
|
0.15
|
1999-02-15
|
1998-10-13
|
0.15
|
1998-11-15
|
1998-07-13
|
0.15
|
1998-08-15
|
1998-04-13
|
0.30
|
1998-05-15
|
1998-01-13
|
0.27
|
1998-02-15
|
1997-10-10
|
0.27
|
1997-11-15
|
1997-07-11
|
0.27
|
1997-08-15
|
1997-04-11
|
0.27
|
1997-05-15
|
1997-01-13
|
0.24
|
1997-02-15
|
1996-10-10
|
0.24
|
1996-11-15
|
1996-07-11
|
0.24
|
1996-08-15
|
1996-04-11
|
0.24
|
1996-05-15
|
1996-01-10
|
0.21
|
1996-02-15
|
1995-10-11
|
0.21
|
1995-11-15
|
1995-07-12
|
0.21
|
1995-08-15
|
1995-04-07
|
0.21
|
1995-05-15
|
1995-01-09
|
0.19
|
1995-02-15
|
1994-10-07
|
0.19
|
1994-11-15
|
1994-07-11
|
0.19
|
1994-08-15
|
1994-04-11
|
0.19
|
1994-05-15
|
1994-01-10
|
0.17
|
1994-02-15
|
1993-10-08
|
0.17
|
1993-11-15
|
1993-07-09
|
0.17
|
1993-08-15
|
1993-04-08
|
0.17
|
1993-05-15
|
1993-01-11
|
0.15
|
1993-02-15
|
1992-10-08
|
0.15
|
1992-11-15
|
1992-07-09
|
0.15
|
1992-08-15
|
1992-04-09
|
0.30
|
1992-05-15
|
1992-01-09
|
0.25
|
1992-02-15
|
1991-10-08
|
0.25
|
1991-11-15
|
1991-07-09
|
0.25
|
1991-08-15
|
1991-04-09
|
0.25
|
1991-05-15
|
1991-01-09
|
0.21
|
1991-02-15
|
1990-10-09
|
0.21
|
1990-11-15
|
1990-07-09
|
0.21
|
1990-08-15
|
1990-04-06
|
0.42
|
1990-05-15
|
1990-01-08
|
0.35
|
1990-02-15
|
1989-10-06
|
0.35
|
1989-11-15
|
1989-07-10
|
0.35
|
1989-08-15
|
1989-04-10
|
0.35
|
1989-05-15
|
1989-01-09
|
0.30
|
1989-02-15
|
1988-10-07
|
0.30
|
1988-11-15
|
1988-07-11
|
0.30
|
1988-08-15
|
1988-04-10
|
0.30
|
1988-05-15
|
1988-01-11
|
0.25
|
1988-02-15
|
1987-10-08
|
0.25
|
1987-11-16
|
1987-07-09
|
0.25
|
1987-08-15
|
1987-04-09
|
0.25
|
1987-05-15
|
1987-01-09
|
0.21
|
1987-02-15
|
1986-10-08
|
0.21
|
1986-11-15
|
1986-07-09
|
0.21
|
1986-08-15
|
1986-04-09
|
0.42
|
1986-05-15
|
1986-01-10
|
0.35
|
1986-02-15
|
1985-10-08
|
0.35
|
1985-11-15
|
1985-07-09
|
0.35
|
1985-08-15
|
1985-04-09
|
0.35
|
1985-05-15
|
1985-01-09
|
0.30
|
1985-02-15
|
1984-10-09
|
0.30
|
1984-11-15
|
1984-07-09
|
0.30
|
1984-08-15
|
1984-04-09
|
0.30
|
1984-05-15
|
1984-01-09
|
0.25
|
1984-02-15
|
1983-10-07
|
0.25
|
1983-11-15
|
1983-07-11
|
0.25
|
1983-08-15
|
1983-04-11
|
0.25
|
1983-05-15
|
1983-01-10
|
0.21
|
1983-02-15
|
1982-10-08
|
0.21
|
1982-11-15
|
1982-07-12
|
0.21
|
1982-08-15
|
1982-04-12
|
0.21
|
1982-05-15
|
1982-01-11
|
0.18
|
1982-02-15
|
1981-10-09
|
0.18
|
1981-11-15
|
1981-07-13
|
0.18
|
1981-08-15
|
1981-04-10
|
0.36
|
1981-05-15
|
1981-01-12
|
0.30
|
1981-02-15
|
1980-10-10
|
0.30
|
1980-11-15
|
1980-07-14
|
0.30
|
1980-08-15
|
1980-04-13
|
0.30
|
1980-05-15
|
1980-01-13
|
0.25
|
1980-02-14
|
1979-10-04
|
0.25
|
1979-11-14
|
1979-07-08
|
0.25
|
1979-08-14
|
1979-04-15
|
0.25
|
1979-05-14
|
1979-01-07
|
0.21
|
1979-02-14
|
1978-10-05
|
0.21
|
1978-11-14
|
1978-07-09
|
0.18
|
1978-08-14
|
1978-04-09
|
0.36
|
1978-05-14
|
1978-01-08
|
0.30
|
1978-02-14
|
1977-10-06
|
0.30
|
1977-11-14
|
1977-07-10
|
0.30
|
1977-08-14
|
1977-04-10
|
0.25
|
1977-05-14
|
